Breathing-Maneuver-Induced Myocardial Oxygenation Reserve Validated by FFR (B-MORE)
- Conditions
- Coronary Artery Stenosis
- Registration Number
- NCT04126148
- Lead Sponsor
- McGill University Health Centre/Research Institute of the McGill University Health Centre
- Brief Summary
The study aims to determine a diagnostic marker for regionally impaired myocardial oxygenation response in patients with suspected coronary artery stenosis.
- Detailed Description
This observational applied research international study aims to assess the validity of breathing maneuvers as a vasoactive maneuver and Oxygenation-Sensitive Cardiac Magnetic Resonance Imaging (OS-CMR) in a patient population. OS-CMR results will be compared to the clinical gold standard of Fractional Flow Reserve (FFR) and instant wave-free ratio (iFR) as a secondary objective, to determine if this non-invasive, no pharmaceutical agent imaging technique can identify areas of oxygenation deficit in myocardium perfused by a stenosed coronary artery.
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 350
Healthy Participants
- Age: > 40y
- No known current or pre-existing significant medical problems that would affect the cardiovascular or respiratory system.
CAD Patients
- Age > 18 y
- Indication for invasive coronary angiography based on symptoms and a test positive for inducible coronary ischemia, or previous coronary angiography.
ALL participants:
- General MRI contraindications: Pacemakers, defibrillating wires, implanted defibrillators, intracranial aneurysm clips, metallic foreign bodies in the eyes, knowledge or suspicion of pregnancy.
- Consumption of caffeine (coffee, tea, cocoa, chocolate, "energy drink") during the 12 hours prior to the exam.
- Regular nicotine consumption during the last 6 months.
Patients only
- Vasoactive medication (e.g. nitro) during the 12 hours prior to the exam Contraindications to adenosine (2nd or 3rd A-V block, sinus node disease, asthma, bronchoconstrictive diseases).
- Acute Coronary Syndrome (ACS), or previous Coronary Artery Bypass Surgery
- Previous myocardial infarction within 1 month
- Clinically unstable condition
- Significant or uncontrolled arrhythmia
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method B-MORE: Diagnostic cut-off - Relative change of myocardial signal intensity 2019-2022 To obtain a diagnostic cut-off of the mean Breathing-Maneuver-induced Myocardial Oxygenation REserve (B-MORE) of a coronary territory as defined by the relative change of myocardial signal intensity (delta SI\[%\]) in oxygenation-sensitive CMR (OS-CMR) images, at the 15s and 30s time point of a post-hyperventilation breath-hold for detecting an associated severe coronary artery stenosis as defined by FFR of less than 0.75 or a QCA assessment of \>0.75, as compared to the global delta SI\[%\] in age-matched healthy volunteers
- Secondary Outcome Measures
Name Time Method 30sec B-MORE Cut-off 2019-2022 A student's t-test will assess a cut-off of the Breathing maneuver induced Myocardial Oxygenation REserve (MORE), at the 30s time point of the breath hold, for a region perfused by a stenosed coronary artery (FFR / iFR or QCA \>0.75) as compared to a healthy coronary artery (FFR / iFR or QCA \<0.75), within a patient.
Relationship between B-MORE and QCA 2019-2022 Pearson's correlation coefficient will be obtained to assess the relationship between B-MORE results at the 15s and 30s time point of the breath-hold and Quantitative Coronary Angiography (QCA) measurements for each coronary territory.
Relationship between B-MORE and FFR / iFR 2019-2022 Pearson's correlation coefficient will be obtained to assess the relationship between B-MORE results at the 15 s and 30s time point of the breath-hold and FFR / iFR measurements for each coronary territory.
Heart rate response to hyperventilation. 2019-2022 Markers of diagnostic accuracy will be obtained to assess the accuracy the heart rate response to hyperventilation.
Myocardial strain response at the 15s and 30s time point during breath-hold 2019-2022 Markers of diagnostic accuracy will be obtained to assess the accuracy of the myocardial strain response at the 15s and 30s time point of the breath-hold
Accuracy of B-MORE and strain response at the 15s and 30s time point of the breath-hold 2019-2022 Markers of diagnostic accuracy will be obtained to assess the accuracy of a combination of the B-MORE and the strain response at the 15s and 30s time point of the breath-hold
B-MORE - strain response at 15s and 30s time breath hold and Heart rate response 2019-2022 Markers of diagnostic accuracy will be obtained to assess the accuracy of a combination of the B-MORE, the strain response at the 15s and 30s time point of the breath-hold, and the heart rate response to hyperventilation
Relationship between B-MORE vs heart rate response to hyperventilation 2019-2022 A student's t-test will assess the relationship between B-MORE results and heart rate response to hyperventilation
Relationship between myocardial strain and Heart rate 2019-2022 A student's t-test will assess the relationship between the strain response at the 15 and 30 s timepoints and heart rate response to hyperventilation
Relationship between B-MORE and myocardial strain measurements -each coronary territory 2019-2022 A student's t-test will assess the relationship between B-MORE results and myocardial strain measurements (circumferential, longitudinal, and radial) at the 15s and 30s time point for each coronary territory.
Global relationship between B-MORE results and myocardial strain measurements 2019-2022 A student's t-test will assess the global relationship between B-MORE results and myocardial strain measurements (circumferential, longitudinal, and radial).
Relationship between B-MORE (15s and 30s) vs QCA 2019-2022 Pearson's correlation coefficient will be obtained to assess the relationship between B-MORE results after hyperventilation and Quantitative Coronary Angiography (QCA) measurements for each coronary territory.
Relationship between B-MORE vs FFR - iFR each coronary territory 2019-2022 To assess the relationship between B-MORE results after hyperventilation and FFR / iFR measurements for each coronary territory.
Relationship between B-MORE vs T1/T2 mapping 2019-2022 Pearson's assess the relationship between B-MORE results and global T1/T2 mapping measurements.
Breathing maneuver - Clinical feasibility 2019-2022 Recorded time, exclusion rate due to inability to perform the breathing maneuvers, will be reported for clinical feasibility during MRI and while performing iFR. Any serious adverse effects of the breathing maneuver will be reported for safety.
B-MORE analysis intra and inter-reader reproducibility 2019-2022 Correlation coefficients will be obtained to evaluate the intra- and inter-reader reproducibility of B-MORE.
Trial Locations
- Locations (1)
McGill University Health Center
🇨🇦Montreal, Quebec, Canada